• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION STERLING; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION STERLING; CATHETER, PERCUTANEOUS Back to Search Results
Model Number 24716
Medical Device Problem Codes Material Rupture (1546); Material Twisted/Bent (2981)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/06/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that a balloon rupture occurred.The 80% stenosed target lesion was located in a calcified and non-tortuous superficial femoral artery (sfa).A fg sterling otw, 5.0x220x150-hybrid balloon catheter was selected for the percutaneous transluminal angioplasty (pta) procedure.Probing the sfa was successful, and the pta was started with the sterling balloon.During the first inflation, however, at 10 atmospheres for one minute, there appeared to be a constriction in the middle of the balloon, and then the balloon ruptured.The balloon was able to be removed as normal, and there were no patient complications reported.
 
Additional Manufacturer Narrative
Device evaluation by manufacturer: returned product consisted of a sterling balloon catheter.The outer shaft, inner shaft, balloon and tip were visually and microscopically examined.Visual examination revealed no damages.Microscopic examination revealed a pinhole in the balloon 16.1cm from the tip.Inspection of the remainder of the device presented no other damage or irregularities.Product analysis confirmed there is a pinhole in the balloon.
 
Event or Problem Description
It was reported that a balloon rupture occurred.The 80% stenosed target lesion was located in a calcified and non-tortuous superficial femoral artery (sfa).A fg sterling otw, 5.0x220x150-hybrid balloon catheter was selected for the percutaneous transluminal angioplasty (pta) procedure.Probing the sfa was successful, and the pta was started with the sterling balloon.During the first inflation, however, at 10 atmospheres for one minute, there appeared to be a constriction in the middle of the balloon, and then the balloon ruptured.The balloon was able to be removed as normal, and there were no patient complications reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERLING
Common Device Name
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17239911
Report Number2124215-2023-31659
Device Sequence Number6840790
Product Code LIT
UDI-Device Identifier08714729845409
UDI-Public08714729845409
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K132430
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/03/2026
Device Model Number24716
Device Catalogue Number24716
Device Lot Number0031368269
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 06/09/2023
Supplement Date Received by Manufacturer08/09/2023
Initial Report FDA Received Date06/30/2023
Supplement Report FDA Received Date08/31/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/04/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-